Innovation to Impact: Wendy Davis, MBA of GestVision and Irina Buhimschi, MD, Director of Perinatal Research at The Research Institute at Nationwide Children’s Hospital
New Rapid Test for Preeclampsia Can Provide Life-Saving Diagnosis: Kara Rood, MD, Ohio State University Wexner Medical Center
Listen to Dr. Rood discuss detecting and navigating the complexities of the progressive disease of preeclampsia on ReachMD here: Unmasking Preeclampsia, the Great Masquerader
GestVision in the News:
Read about new results from The Ohio State University Wexner Medical Center about the Congo Red Dot Paper Test, a diagnostic that detects misfolded proteins in the urine of pregnant women similarly to the GestAssured® Test in eMedicineHealth, Healthline, Healio, The Lantern, Medscape, and USA Today.
Connecticut Technology Council 2017 Women of Innovation® Entrepreneurial Innovation and Leadership Award goes to Wendy Davis (announced April 24, 2017).
GestVision received the United States Patent and Trademark Office (USPTO) Patents for Humanity Award on November 16, 2016.
Simple test allows for rapid diagnosis of preeclampsia – American Association for the Advancement of Science (AAAS) EurekAlert!, February 4, 2016
Women-owned startup receives $2 million in strategic funding for lifesaving diagnostic test for pregnant women – America’s Small Business Development Centers (SBDC) Connecticut, February 2, 2016
Yale Company GestVision Raises Series A to Develop First-of-its-Kind Preeclampsia Test – Yale Entrepreneurial Institute, February 1, 2016
US Small Business Administration InnovateHER Finalist, April 17, 2015
For EMBA Alumna, Yale SOM Was Key to Launching Biotech Firm – Yale School of Management, February 2, 2015
Dyeing to diagnose preeclampsia – Nature Science-Business Exchange (SciBX), August 7, 2014
Connecticut Technology Council announces GestVision as one of the Connecticut Innovation Summit’s 2014 Tech Companies to Watch in the Life Sciences category.
Saving Lives Profile: Pinpointing Preeclampsia with a Simple Red Dot – US Aid Frontlines, September/October 2013
For media inquiries, please contact:
+1 914-701-0100 ext. 5354